Search for content, post, videos

Atlas Antibodies enters agreement with T-Cure Bioscience

Nille Klæbel
The two companies have announced a collaborative agreement for the development, manufacture, and supply of CT83 (KK-LC-1) mAb. These will be used to develop a diagnostic test to identify tumors that express KK-LC-1. Patients with KK-LC-1 positive tumors may be eligible inclusion in clinical trial
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.